DOJ Intensifies Anti-Kickback Statute Enforcement in Telehealth Referral and Marketing Arrangements
Overview of the Anti-Kickback Statute (AKS)
The federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b(b)) is a cornerstone of federal healthcare fraud and abuse law. Enacted to protect patients and federal healthcare programs from fraud and abuse, the AKS prohibits anyone from knowingly and willfully offering, paying, soliciting, or receiving any remuneration—directly or indirectly, overtly or covertly, in cash or in kind—to induce or reward referrals for items or services reimbursable by a federal healthcare program. Violations of the AKS can result in severe penalties, including criminal fines, imprisonment, civil monetary penalties, and exclusion from participation in federal healthcare programs.
The statute is intentionally broad, covering any arrangement where even one purpose of the remuneration is to induce referrals. This broad interpretation means that many common business practices, if not carefully structured, could be deemed illegal kickbacks. To provide some clarity and protection, the Department of Health and Human Services (HHS) Office of Inspector General (OIG) has established a series of statutory and regulatory safe harbors. These safe harbors protect certain payment and business practices that, while potentially implicating the AKS, are not considered an offense under the statute if all specified conditions are met. Examples include discounts, employment relationships, and certain personal services and management contracts.
DOJ's Heightened Scrutiny on Telehealth and Referral Arrangements
In recent years, the Department of Justice (DOJ) has significantly ramped up its enforcement efforts against healthcare fraud, with a particular focus on the rapidly expanding telehealth sector. The COVID-19 pandemic accelerated the adoption of telehealth, leading to a surge in new providers and innovative business models. While telehealth offers undeniable benefits in terms of access to care, it also introduced new avenues for potential fraud and abuse, particularly concerning patient recruitment, marketing, and referral arrangements.
The DOJ, often working in conjunction with the OIG and other law enforcement agencies, has repeatedly highlighted its commitment to prosecuting individuals and entities that exploit federal healthcare programs through illegal kickbacks. This focus is not new, but its application to telehealth business models has become more pronounced. Investigations and enforcement actions frequently target arrangements where telehealth companies, laboratories, pharmacies, or other providers pay kickbacks to marketers, lead generators, or even other clinicians to induce referrals of federal healthcare program beneficiaries.
These schemes often involve:
- Payments for patient leads: Telehealth companies paying marketing firms or individuals a per-patient fee for generating referrals, especially if those patients are Medicare or Medicaid beneficiaries.
- Arrangements with prescribing providers: Telehealth platforms or pharmacies offering financial incentives to prescribers for ordering specific tests, durable medical equipment (DME), or medications.